...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith Epigenetics Corp. Commences Operations
Reply New Message
Prev Message Back To Forum Threaded View Next Message

I will say this, if and when a Zenith IPO is launched, I will 100% not be selling not 1 share,

If RVX 208 succeeds the phase 3 betonmace trial, Zenith shares will be worth a ton of $$$,

This blood bank and IP they own could be worth billions.......... in the next 2 to 3 years assuming RVX succeeds

4 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply